Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | P21 | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | 1 uM | |||||
Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
Quantitative Method |
SILAC
|
|||||
Competitor Name | P27 | Competitor Info | ||||
Competitor Concentration | 10 uM | |||||
In Vivo Experiment Model | Model Type |
|
Living cell | |||
Derived Tissue |
|
Pancreas | ||||
Disease Model | Pancreatic ductal adenocarcinoma [ICD-11:2C10] | |||||
Model Name | Human pancreatic ductal adenocarcinoma cells (BxPC-3) | |||||
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP01675 | Antiviral innate immune response receptor RIG-I (RIGI) | 426.8 | ||||
LDTP12538 | Ras-related protein Rab-6B (RAB6B) | 7.0 | ||||
LDTP02021 | Ornithine aminotransferase, mitochondrial (OAT) | 2.0 | ||||
LDTP02095 | Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCA) | 1.9 | ||||
LDTP02175 | Epoxide hydrolase 1 (EPHX1) | 1.3 |
Immunoglobulin
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP01417 | Contactin-5 (CNTN5) | 11.2 |
Other
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP03755 | Keratin, type I cytoskeletal 9 (KRT9) | 3.0 | ||||
LDTP11140 | Peroxiredoxin-like 2A (PRXL2A) | 2.5 | ||||
LDTP04500 | Heterogeneous nuclear ribonucleoprotein M (HNRNPM) | 1.9 | ||||
LDTP04880 | Small ribosomal subunit protein uS10 (RPS20) | 1.9 | ||||
LDTP01534 | Luc7-like protein 3 (LUC7L3) | 1.7 |